1 | existing | 5,631 |
2 | ordinary | 476 |
3 | official | 435 |
4 | prevailing | 306 |
5 | extant | 206 |
6 | authentic | 199 |
7 | upcoming | 185 |
8 | incoming | 121 |
9 | authoritative | 71 |
10 | fide | 50 |
11 | existent | 44 |
12 | rct-based | 18 |
13 | uniformed | 18 |
14 | a-level | 15 |
15 | agreed-upon | 11 |
16 | askina | 9 |
17 | post-publication | 7 |
18 | sub-standard | 7 |
19 | harm-minimization | 6 |
20 | pen-3 | 6 |
21 | less-effective | 5 |
22 | oct-derived | 5 |
23 | resource-intense | 5 |
24 | fhs-derived | 4 |
25 | monotheistic | 4 |
26 | sample-specific | 4 |
27 | star*d. | 4 |
28 | 2-year-long | 3 |
29 | aboriginal-specific | 3 |
30 | appropriately-sized | 3 |
31 | biomass-based | 3 |
32 | chronobiologic | 3 |
33 | isoxazolyl | 3 |
34 | multi-omics | 3 |
35 | nonfluoroquinolone | 3 |
36 | oligo-dt | 3 |
37 | oncology-specific | 3 |
38 | ra-specific | 3 |
39 | women-initiated | 3 |
40 | hiv-relevant | 2 |
41 | ido-nonexpressing | 2 |
42 | kaolack | 2 |
43 | plant-beneficial | 2 |
44 | tooth-level | 2 |
45 | unsmoothed | 2 |
46 | 5'-utr-mediated | 1 |
47 | another.some | 1 |
48 | consensus-directed | 1 |
49 | fcp-induced | 1 |
50 | fever.a | 1 |
51 | forces/naval/police/rescue | 1 |
52 | foreign-based | 1 |
53 | foucaultian | 1 |
54 | half-dried-out | 1 |
55 | leukocyte-removing | 1 |
56 | limmited | 1 |
57 | luria׳s | 1 |
58 | metaheuristics-assisted | 1 |
59 | modulated-temperature | 1 |
60 | nonmendelian | 1 |
61 | parent-progeny | 1 |
62 | pcr-selective | 1 |
63 | subject-object | 1 |
64 | traditionally-used | 1 |
65 | treatment-at | 1 |
66 | vertigo-dizziness | 1 |
1 | 2-year-long | 3 |
2 | 5'-utr-mediated | 1 |
3 | a-level | 15 |
4 | aboriginal-specific | 3 |
5 | agreed-upon | 11 |
6 | another.some | 1 |
7 | appropriately-sized | 3 |
8 | askina | 9 |
9 | authentic | 199 |
10 | authoritative | 71 |
11 | biomass-based | 3 |
12 | chronobiologic | 3 |
13 | consensus-directed | 1 |
14 | existent | 44 |
15 | existing | 5,631 |
16 | extant | 206 |
17 | fcp-induced | 1 |
18 | fever.a | 1 |
19 | fhs-derived | 4 |
20 | fide | 50 |
21 | forces/naval/police/rescue | 1 |
22 | foreign-based | 1 |
23 | foucaultian | 1 |
24 | half-dried-out | 1 |
25 | harm-minimization | 6 |
26 | hiv-relevant | 2 |
27 | ido-nonexpressing | 2 |
28 | incoming | 121 |
29 | isoxazolyl | 3 |
30 | kaolack | 2 |
31 | less-effective | 5 |
32 | leukocyte-removing | 1 |
33 | limmited | 1 |
34 | luria׳s | 1 |
35 | metaheuristics-assisted | 1 |
36 | modulated-temperature | 1 |
37 | monotheistic | 4 |
38 | multi-omics | 3 |
39 | nonfluoroquinolone | 3 |
40 | nonmendelian | 1 |
41 | oct-derived | 5 |
42 | official | 435 |
43 | oligo-dt | 3 |
44 | oncology-specific | 3 |
45 | ordinary | 476 |
46 | parent-progeny | 1 |
47 | pcr-selective | 1 |
48 | pen-3 | 6 |
49 | plant-beneficial | 2 |
50 | post-publication | 7 |
51 | prevailing | 306 |
52 | ra-specific | 3 |
53 | rct-based | 18 |
54 | resource-intense | 5 |
55 | sample-specific | 4 |
56 | star*d. | 4 |
57 | sub-standard | 7 |
58 | subject-object | 1 |
59 | tooth-level | 2 |
60 | traditionally-used | 1 |
61 | treatment-at | 1 |
62 | uniformed | 18 |
63 | unsmoothed | 2 |
64 | upcoming | 185 |
65 | vertigo-dizziness | 1 |
66 | women-initiated | 3 |
1 | star*d. | 4 |
2 | pen-3 | 6 |
3 | fever.a | 1 |
4 | askina | 9 |
5 | ra-specific | 3 |
6 | sample-specific | 4 |
7 | aboriginal-specific | 3 |
8 | oncology-specific | 3 |
9 | chronobiologic | 3 |
10 | authentic | 199 |
11 | monotheistic | 4 |
12 | fcp-induced | 1 |
13 | unsmoothed | 2 |
14 | uniformed | 18 |
15 | foreign-based | 1 |
16 | biomass-based | 3 |
17 | rct-based | 18 |
18 | traditionally-used | 1 |
19 | 5'-utr-mediated | 1 |
20 | women-initiated | 3 |
21 | consensus-directed | 1 |
22 | limmited | 1 |
23 | metaheuristics-assisted | 1 |
24 | fhs-derived | 4 |
25 | oct-derived | 5 |
26 | appropriately-sized | 3 |
27 | sub-standard | 7 |
28 | fide | 50 |
29 | another.some | 1 |
30 | nonfluoroquinolone | 3 |
31 | modulated-temperature | 1 |
32 | resource-intense | 5 |
33 | forces/naval/police/rescue | 1 |
34 | authoritative | 71 |
35 | less-effective | 5 |
36 | pcr-selective | 1 |
37 | prevailing | 306 |
38 | incoming | 121 |
39 | upcoming | 185 |
40 | ido-nonexpressing | 2 |
41 | existing | 5,631 |
42 | leukocyte-removing | 1 |
43 | 2-year-long | 3 |
44 | kaolack | 2 |
45 | plant-beneficial | 2 |
46 | official | 435 |
47 | a-level | 15 |
48 | tooth-level | 2 |
49 | isoxazolyl | 3 |
50 | nonmendelian | 1 |
51 | foucaultian | 1 |
52 | post-publication | 7 |
53 | harm-minimization | 6 |
54 | agreed-upon | 11 |
55 | multi-omics | 3 |
56 | vertigo-dizziness | 1 |
57 | luria׳s | 1 |
58 | treatment-at | 1 |
59 | subject-object | 1 |
60 | oligo-dt | 3 |
61 | extant | 206 |
62 | hiv-relevant | 2 |
63 | existent | 44 |
64 | half-dried-out | 1 |
65 | parent-progeny | 1 |
66 | ordinary | 476 |